Significance of silent ischemia andmicroalbuminuria in predicting coronaryevents in asymptomatic patients with type 2 diabetes
Martin K. Rutter, MB ChB, MRCP*,*,
Shahid T. Wahid, MB BS, MRCP*,
Janet M. McComb, MD, FRCP and
Sally M. Marshall, MD, FRCP*
* Department of Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
Regional Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, United Kingdom

View larger version (14K):
[in a new window]
|
Figure 1 Coronary event-free survival in asymptomatic patients with type 2 diabetes with (dotted line) and without (solid line) silent myocardial ischemia. p = 0.003 (log-rank test).
|
|

View larger version (13K):
[in a new window]
|
Figure 2 Coronary event-free survival in asymptomatic patients with type 2 diabetes with (dotted line) and without (solid line) microalbuminuria. p = 0.03 (log-rank test).
|
|

View larger version (14K):
[in a new window]
|
Figure 3 Coronary event-free survival in asymptomatic patients with type 2 diabetes in the following subgroups: 1) neither silent myocardial ischemia (SMI) nor microalbuminuria (MA); 2) SMI but not MA; 3) MA but not SMI; and 4) both SMI and MA. p = 0.03, comparing group 1 with remaining patients; p = 0.0008, comparing group 4 with remaining patients.
|
|
|